Skip to main content
Premium Trial:

Request an Annual Quote

The Real-time In-depth-ome

Stanford researcher Michael Snyder has been studying his own genome for two years, and now the results of his study have been published in Cell, reports Popular Science's Rebecca Boyle. Snyder and his team have been studying his genome, transcriptome, metabolome, and proteome in an effort to make as detailed a personal 'omics profile as possible. "They watched in real time and at the molecular level as viruses attacked his cells, and they figured out, to their shock, that he was prone to developing type 2 diabetes. And then they watched him develop it," Boyle says. "It's the first study to follow the molecular processes of sickness and health in one individual, and as such it's a major breakthrough for personalized medicine. It's also the first real-time view of the birth of a disease that afflicts millions of people."

With a bit of tongue in cheek, Nature News' Carina Dennis calls the study "the rise of the narciss-ome," adding that the future of personalized medicine "can be glimpsed today" in Snyder's paper. "As a proof-of-principle example of personalized genomic medicine, it is distinct from other studies because it applies whole-genome diagnostics to a healthy person rather than to individuals with disease," she says.

Daily Scan's sister publication, GenomeWeb Daily News, has more on Snyder's study here.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.